Börje Ekholm is proposed as new Chair of the Sobi Board of Directors
Sobi (BIOVF) has proposed Börje Ekholm as its next Board Chair, with election planned for the 2027 Annual General Meeting.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Sobi (BIOVF) has proposed Börje Ekholm as its next Board Chair, with election planned for the 2027 Annual General Meeting.
The Nomination Committee proposes electing Ekholm as both a Board member and Chair. Current Chair David Meek will not seek re-election and will remain in office through the end of his term in May 2027. Ekholm recently stepped down as Ericsson CEO and previously led Patricia Industries and Investor. While at Investor, he was involved in Sobi's creation through the merger of Biovitrum and Swedish Orphan International. The committee's complete proposals will be published before the meeting.
AI-generated analysis. How Rhea-AI works. Not financial advice.
The Nomination Committee of Swedish Orphan Biovitrum AB (Sobi®) proposes that Börje Ekholm is elected as new Board member and Chair of the Board at the 2027 Annual General Meeting (AGM).
David Meek has been a member of Sobi's Board and Chair since December 2024 and will continue to serve as Chair for the remainder of his term to May 2027. During his tenure, Sobi has delivered strong growth and shareholder return, expanded access to its medicines through new launches and indication extensions, and strengthened its clinical development pipeline, supporting the company's long-term growth ambitions.
Börje Ekholm brings more than 30 years of experience across technology, investment management and international business leadership. He recently stepped down as CEO of Ericsson and has previous CEO experience from Patricia Industries and Investor AB. Börje Ekholm currently serves as Chair of the Board of Trimble Inc. and has recently been appointed to the Board of Nasdaq Inc. effective November 1, 2026. His previous Board assignments include Alibaba, Husqvarna, Nasdaq (Chair), Scania and WM Data (Chair). He is also a board advisor for Mars Inc. and an advisor to the CEO of Ericsson. During his CEO tenure at Investor Börje Ekholm was involved in the creation of Sobi through the merger of Biovitrum and Swedish Orphan International and worked with the company from an owner perspective.
"We are pleased to propose Börje Ekholm as the new Chair of the Sobi Board. Börje has significant global leadership and board experience and is very familiar with the company. The Nomination Committee would like to express our sincere gratitude to David for the strong performance and successful development of the company under his leadership", says Daniel Nodhäll, Chair of the Nomination Committee.
The Nomination Committee's complete proposals will be published in due time before the 2027 AGM.
Sobi®
More about Sobi at sobi.com and LinkedIn.
Contacts
Sobi is a global biopharma company unlocking the potential of breakthrough innovations, transforming everyday life for people living with rare diseases. Sobi has approximately 2,000 employees across
This information is information that Sobi is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, on 29 October 2026 at 19:45 CET.
Gerard Tobin
Head of Investor Relations
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
|
https://mb.cision.com/Public/14266/4417516/afe6f5f740b78f84.pdf |
Sobi Press release Proposed new Chair of the Sobi Board of Directors |
View original content:https://www.prnewswire.com/news-releases/borje-ekholm-is-proposed-as-new-chair-of-the-sobi-board-of-directors-302924318.html
SOURCE Swedish Orphan Biovitrum AB
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Who is proposed to replace David Meek as Sobi Board Chair?
The Nomination Committee proposes Börje Ekholm as a new Board member and Chair at Sobi's 2027 Annual General Meeting. David Meek will not stand for re-election and will continue as Chair for the remainder of his term to May 2027.